NDC 61958-1805 – Harvoni
Ledipasvir 33.75 mg/1; Sofosbuvir 150 mg/1 · Pellet · Oral
Product NDC61958-1805
Product details
- Brand name
- Harvoni
- Generic name
- ledipasvir and sofosbuvir
- Labeler
- Gilead Sciences, Inc
- Dosage form
- Pellet
- Route
- Oral
- Marketing category
- NDA · NDA212477
- Marketed since
- August 28, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis C Virus NS5A Inhibitor; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Active ingredients
- Ledipasvir 33.75 mg/1
- Sofosbuvir 150 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61958-1805-1 | 90 PELLET in 1 PACKET (61958-1805-1) | Aug 28, 2019 |
Other Harvoni products
- 61958-1801 Ledipasvir 90 mg/1; Sofosbuvir 400 mg/1 · Tablet, Film Coated · Gilead Sciences, Inc
- 61958-1803 Ledipasvir 45 mg/1; Sofosbuvir 200 mg/1 · Tablet, Film Coated · Gilead Sciences, Inc
- 61958-1804 Ledipasvir 45 mg/1; Sofosbuvir 200 mg/1 · Pellet · Gilead Sciences, Inc